#cognitive function

Antiretroviral treatment of HIV may combat and even halt the harmful effects the virus appears to have on brain aging and cognitive function

Sustiva (efavirenz), which is included in Atripla, is associated with central nervous system side effects and sleep disturbances.

A look at the most notable HIV-related studies presented at the 2017 Conference on Retroviruses and Opportunistic Infections in Seattle.

More research is needed into how the virus may affect cerebral small vessel disease, a leading cause of cognitive decline.

However, in a recent small study, hepatitis C treatment was not associated with an improvement in cognitive impairment in this population.

It’s part of San Francisco General Hospital’s Ward 86, where 1,600 of its 2,500 patients are 50 or older.

Cognitive decline has been a major concern for people living with HIV as they age.

Currently, women and heterosexual men who inject drugs in King County, Washington, have a low HIV rate.

The ongoing study includes those with and without HIV, which is associated with declining cognitive function.

Findings suggest that the older class of HIV drugs may contribute to HIV-associated neurocognitive disorders.

Among a group of middle-aged men with well-treated HIV, there was also a link between cognitive decline and a gene connected to Alzheimer’s.

HIV-positive San Francisco residents above age 50 have a high rate of problems related to aging.

Clinicians at Georgetown University have reported the first case of a person living with HIV receiving a diagnosis of Alzheimer’s disease.

People with HIV who have mild cognitive impairment are at increased risk of developing symptoms of impairment.

Individuals who start HIV treatment very soon after contracting the virus may be at lesser risk of later developing cognitive decline.

People with HIV who have asymptomatic neurocognitive impairment are at increased risk of developing symptomatic impairment.